Anavex Life Sciences Corp (AVXL)

[Steady_T]

The only real issue with Missling is his chosen communication approach. You and a number of others don't like it and are calling for his head.

As far as the n for the pediatric Rett trial, that was chosen by the trial designer based on previous strong results. I doubt that Missling designed the trial himself. Yeah, I get he approved the design so if you want to hold him accountable that's fine, but that is not his expertise. Anavex has staff that do that.

AD MAA process has started. US NDA is waiting on the OLE data before submission. A new CEO won't change that.

Rett is waiting on the FDA and possibly the OLE data. A new CEO won't change that.

Peer review paper is whatever it is. A new CEO won't change that.

Financial position for the company is great. A new CEO won't change that.

So a new CEO would basically change the communication approach and little else. Perhaps start more trials with the attendant reduction in the overall financial position.